ENTA Enanta Pharmaceuticals, Inc. Common Stock

Data is currently not available
Upcoming
Latest News

Quotes

NEWS & ANALYSIS

Data is currently not available
Previous
Close  

Key Data

Data is currently not available

News

Enanta Pharmaceuticals Announces the Appointment of Mark G. Foletta to Its Board of Directors

Press Release • 5 days ago

Enanta Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference

Press Release • Jun 11, 2020

Enanta Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

Press Release • May 12, 2020

Enanta Pharmaceuticals Inc (ENTA) Q2 2020 Earnings Call Transcript

The Motley Fool • May 7, 2020

FDA Decision On BMY's Drug Postponed, ENTA's PBC Study Fails, MGNX Turns Heads

RTTNews • May 6, 2020

Enanta Announces Results of INTREPID Study of EDP-305 for the Treatment of Primary Biliary Cholangitis

Press Release • May 6, 2020

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET

Press Release • May 6, 2020
See All News

Active stocks by Dollar Volume

AMZN

Data is currently not available
AAPL

Data is currently not available
TSLA

Data is currently not available
INTC

Data is currently not available
Data is currently not available
Data is currently not available
Key Executives
Name Title

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders.

  • Real-time Data is provided using Nasdaq Last Sale Data